125 related articles for article (PubMed ID: 36076204)
21. G6PD deficiency in Latin America: systematic review on prevalence and variants.
Monteiro WM; Val FF; Siqueira AM; Franca GP; Sampaio VS; Melo GC; Almeida AC; Brito MA; Peixoto HM; Fuller D; Bassat Q; Romero GA; Maria Regina F O; Marcus Vinícius G L
Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):553-68. PubMed ID: 25141282
[TBL] [Abstract][Full Text] [Related]
22. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.
Chen I; Poirot E; Newman M; Kandula D; Shah R; Hwang J; Cohen JM; Gosling R; Rooney L
Malar J; 2015 May; 14():204. PubMed ID: 25971688
[TBL] [Abstract][Full Text] [Related]
23. Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh.
Engel N; Ghergu C; Matin MA; Kibria MG; Thriemer K; Price RN; Ding XC; Howes RE; Ley B; Incardona S; Alam MS
Malar J; 2021 May; 20(1):217. PubMed ID: 33980257
[TBL] [Abstract][Full Text] [Related]
24. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
Luzzatto L; Seneca E
Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
[TBL] [Abstract][Full Text] [Related]
25. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Djigo OKM; Ould Khalef Y; Ould Ahmedou Salem MS; Gomez N; Basco L; Briolant S; Ould Mohamed Salem Boukhary A
Infect Dis Poverty; 2021 Aug; 10(1):105. PubMed ID: 34353361
[TBL] [Abstract][Full Text] [Related]
26. Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
Adhikari B; Awab GR; von Seidlein L
Malar J; 2021 Mar; 20(1):164. PubMed ID: 33757538
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of primaquine and its metabolites in African males.
Chotsiri P; Mahamar A; Diawara H; Fasinu PS; Diarra K; Sanogo K; Bousema T; Walker LA; Brown JM; Dicko A; Gosling R; Chen I; Tarning J
Malar J; 2024 May; 23(1):159. PubMed ID: 38773528
[TBL] [Abstract][Full Text] [Related]
28. Reinventing primaquine for endemic malaria.
Baird JK
Expert Opin Emerg Drugs; 2012 Dec; 17(4):439-44. PubMed ID: 22998791
[TBL] [Abstract][Full Text] [Related]
29. Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019-2020.
Aung PL; Soe MT; Soe TN; Oo TL; Win KM; Cui L; Kyaw MP; Sattabongkot J; Okanurak K; Parker DM
Sci Rep; 2023 Apr; 13(1):5963. PubMed ID: 37045879
[TBL] [Abstract][Full Text] [Related]
30. G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
Sepúlveda N; Grignard L; Curry J; Mahey L; Bastiaens GJH; Tiono AB; Okebe J; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Lanke K; Sirima SB; Dicko A; d'Alessandro U; Clark TG; Campino S; Chen I; Eziefula AC; Gosling R; Bousema T; Drakeley C
Front Genet; 2021; 12():645688. PubMed ID: 33897764
[TBL] [Abstract][Full Text] [Related]
31. Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth.
Macías Saint-Gerons D; Rodovalho S; Barros Dias ÁL; Lacerda Ulysses de Carvalho A; Beratarrechea A; Monteiro WM; Barata Machado M; Fernandes da Costa C; Yoshito Wada M; de Almeida MHMF; Silva de Matos Fonseca R; Mota Cordeiro JS; Antolini APR; Nepomuceno JA; Fleck K; Simioni Gasparotto F; Lacerda M; Rojas-Cortés R; Pal SN; Porrás AI; Ade MP; Castro JL
Malar J; 2022 Jan; 21(1):28. PubMed ID: 35093070
[TBL] [Abstract][Full Text] [Related]
32. Glucose-6-phosphate dehydrogenase deficiency among children attending the Emergency Paediatric Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Isaac I; Mainasara A; Erhabor O; Omojuyigbe S; Dallatu M; Bilbis L; Adias T
Int J Gen Med; 2013; 6():557-62. PubMed ID: 23874116
[TBL] [Abstract][Full Text] [Related]
33. Glucose-6-phosphate dehydrogenase deficiency and psychotic disorders: A systematic review.
Gandar C; Scott JG; Warren N
World J Biol Psychiatry; 2024 Feb; 25(2):151-159. PubMed ID: 38044502
[TBL] [Abstract][Full Text] [Related]
34. Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.
Huang Z; Li Z; Li Y; Cao Y; Zhong S; Liu J; Lin Z; Lin L; Fang Y; Zeng J; Su Z; Li H; Liang J; Zhu B; Lin Z; Huang Y; Yang X; Jiang L
Ann Lab Med; 2024 May; ():. PubMed ID: 38699793
[TBL] [Abstract][Full Text] [Related]
35. Colorectal Cancer Mortality in Relation to Glucose - 6 - Phosphate Dehydrogenase Deficiency and Consanguinity in Sardinia: A Spatial Correlation Analysis.
Pes GM; Bassotti G; Dore MP
Asian Pac J Cancer Prev; 2017 Sep; 18(9):2403-2407. PubMed ID: 28950694
[TBL] [Abstract][Full Text] [Related]
36. Medications and Acute Hemolysis in G6PD-Deficient Patients - A Real-World Study.
Gronich N; Rosh B; Stein N; Saliba W
Clin Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38842030
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
